Main > > >PULMONARY ARTERIAL HYPERTENSION. *

---

Cardio.>Pulmonary Arterial Hypertension. Treat.: Epoprostenol for Inj.
USA Approval Date: 2005. 06.
USA Launch Date : 2010. 04.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.01.




Cardio.>Pulmonary Arterial Hypertension. Treat.: Macitentan Tablets.
DE Launch Date : 2014. 01.
JP Launch Date : 2015. 06.
USA Launch Date : 2013. 11.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.19.




Cardio.>Pulmonary Arterial Hypertension. Treat.: Selexipag Tablets.
DE Launch Date : 2016. 06.
USA Launch Date: 2016. 01.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.19.




Cardio.>Pulmonary Arterial Hypertension. Treat.: Treprostinil. Implant System.
Synthetic Analog of Prostacyclin.
USA Approval Date: 2018. 07.31.
(*) Companies; Patents; TradeMarks &
Web-Site Available on Request.
UpDate: 2020. 03.02.




Cardio.>Pulmonary Arterial Hypertension. Treat.: Treprostinil Inhalation Solu-tion. Synthetic Analog of Prostacyclin.
USA Approval Date: 2009. 07.30.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 07.26.




Cardio.>Pulmonary Arterial Hypertension. Treat.: Treprostinil. Injection. SubCu- taneous.
Synthetic Analog of Prostacyclin.
USA Approval (Drug) Date: ?
USA Approval (Pump) Date: 2020. 02.24.>
>PreFillable by Specialty Pharmacies.
(*) Companies; Patents; TradeMarks &
Web-Sites Available on Request.
UpDate: 2020. 03.02.




Cardio.>Pulmonary Arterial Hypertension. Treat.: Treprostinil. Oral. ER Tablets.
Synthetic Analog of Prostacyclin.
USA Approval Date: 2013. 12.20.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 03.02.




Treat.: AmbriSentan Tablets. Brand
EU & USA Approved.
Companies: Gilead (USA); GSK (EU)
Patent : Expired
TradeMark: Letairis (USA)
www.letairis.com
TradeMark: Volibris (EU)
UpDate : 2019. 04.18.




Treat.: Beraprost Na (ProstaCyclin)
JP Approval Date: 2007. 10.19.
JP Launch Date: 2007. 12.18.
(*) Companies : Astellas Pharma.
Toray Industries.
Patent : Expired
TradeMark : Careload LA
UpDate: 2019. 04.18.




Treat.: BoSentan Tablets/Bosentan Ta-
blets for Oral Suspension. Brand.
(*) Company : Actelion Pharma.
Patent : Expired
TradeMark: TRACLEER
Web-Site : www.tracleer.com/
UpDate: 2019. 04.01.




Treat.: BoSentan Tablets/Bosentan Ta-
blets for Oral Suspension. Generic.
USA Launch Date: 2019. 06.19.
(*) Company: Teva Pharma.
UpDate: 2019. 10.04.




Treat.: EpoProstenol Na for Inj.
Company : GSK
Patent : Expired
TradeMark: Flolan
UpDate: 2019. 04.18.




Treat.: IloProst Inhalation Solution.
Company (EU) : Bayer.
Company (USA): Actelion Pharma.
Patent : Expired.
TradeMark : Ventavis
Web-Site (USA): www.4ventavis.com
UpDate: 2019. 04.19.




Treat.: Sildenafil Citrate.
Company : Pfizer.
Patent : Expired
TradeMark: Revatio.
Web-Site : www.revatio.com
UpDate: 2019. 04.19.




Treat.: Tadalafil.
Company : United Therapeutics.
Patent : Expired
TradeMark: Adcirca
Web-Site : www.adcirca.com
UpDate: 2019. 04.19.







>PULMONARY ARTERIAL HYPERTENSION. *'s products
This section has no products